This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Total nuclearmedicine patient study volumes decreased by 5.7% increase in nonhospital-based studies, according to the newly published IMV 2024 NM Market Outlook Report. Specifically considering cardiovascular nuclearmedicine procedures, total procedures have decreased by 7.1% between 2021 and 2023, with a 10.7%
tim.hodson Thu, 11/07/2024 - 11:25 Nov. 1, 2024 — The Centers for Medicare & Medicaid Services (CMS) have announced a significant adjustment to the Hospital Outpatient Prospective Payment System (HOPPS). Thursday, November 7, 2024 - 11:25 SNMMI offers special thanks to its partner organizations for their vital support.
milla1cf Mon, 06/10/2024 - 18:17 June 10, 2024 — Carolyn J. Anderson , PhD, a trailblazer in nuclearmedicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. Louis , Missouri, where she worked more than 20 years developing PET and radiopharmaceutical therapy agents.
Who made it to the final round in the 2024 edition of the Minnies, AuntMinnie.com 's event recognizing excellence in radiology? Louis, MO A first-time Minnies finalist, Dmitry Beyder exemplifies how the role of the nuclearmedicine technologist can evolve. Dmitry Beyder.
milla1cf Thu, 06/13/2024 - 20:53 June 13, 2024 — The Society of NuclearMedicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians, technologists, pharmacists, laboratory professionals, scientists and others earlier this week at its 2024 Annual Meeting in Toronto, Ontario. Themed “Innovate.
milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc. This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb).
milla1cf Wed, 06/12/2024 - 21:58 June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI , chair of the Isotope Research and Production Department at Brookhaven National Laboratory in Upton, New York, has been named as president for the Society of NuclearMedicine and Molecular Imaging (SNMMI).
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
year over year, according to the newly published IMV 2024 PET Market Summary Report. In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. Davin Korstjens is a Senior Market Research Program Manager at IMV Medical Information Division, part of Science and Medicine Group.
As nuclearmedicine therapies gain stature compared to nuclearmedicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclearmedicine technologists means a theranostics center may need to limit its patient volume.
The following is the list of candidates for the 2024 edition of the Minnies, AuntMinnie.com 's campaign to recognize the best and brightest in medical imaging. Lindquester, et al, Journal of the American College of Radiology , July 1, 2024. Francisco, et al, Emergency Radiology , April 26, 2024.
With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.
It's only been a few years since a dedicated track in nuclearmedicine and molecular imaging was established at the meeting, and the practice already dominates it. All studies in the sole slated session on novel radiopharmaceuticals this year are on FAPI-PET tracers. 9:10 a.m. | 8:40 a.m. |
TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.
I congratulate Marco Campione on this CEO appointment and we look forward to drawing upon his strategic, operational and broad general business expertise as we increase our global leadership throughout the diagnostic radiopharmaceutical industry,” said Fulvio Renoldi Bracco, CEO of Bracco Imaging. Bracco Imaging S.p.A.,
but votes were still being counted for the 2024 edition of the Minnies. Congratulations to all the winners of the 2024 Minnies awards, and also to the runners-up and the hundreds of candidates who made the semifinalist list and finalist list. Most Influential Radiology Researcher Minnies 2024 Winner: Erik H. Fishman, MD.
milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1
The Society of NuclearMedicine and Molecular Imaging (SNMMI) has bestowed its Georg Charles de Hevesy Nuclear Pioneer award on Carolyn Anderson, PhD, of the University of Missouri-Columbia (MU). The award honors those who have made outstanding contributions in the field of nuclearmedicine, the SNMMI said.
SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As She will also raise awareness of nuclearmedicine’s value to clinical colleagues and patients and will be laser-focused on breaking down barriers to radiopharmaceutical availability, reimbursement, affordability, and funding.
A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. He also helped lead the theranostics conference at the Society of NuclearMedicine and Molecular Imaging (SNMMI) 2024 midwinter meeting. However, few freestanding theranostics centers exist today. Hope added.
milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.
milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.
reduction in average Medicare payment rates compared with 2024, the CMS has estimated there will be a 0% change to reimbursement for radiology, nuclearmedicine, and radiation oncology. increase in the conversion factor from 2024, rising to $89.16 Although the 2025 MPFS calls for an overall 2.9%
Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.
The facility will include cleanrooms and analytical and microbiological labs necessary for high-volume production of lutetium-177 and terbium-161 isotopes, which are used in targeted nuclearmedicine therapies for cancer patients.
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
For the practice of precision care in molecular imaging and nuclearmedicine, this begins with the production of radioisotopes for use in diagnostic tracers, which are administered to patients, attach to specific biomarkers, and release radioactive emissions to provide clinicians detailed molecular information unique to each patient.
A new AI PET/CT tool can assess patient cancer risk, predict tumor response, and estimate survival, according to research findings delivered June 10 at the Society of NuclearMedicine and Molecular Imaging (SNMMI) annual meeting in Toronto.
Evans, PhD, has been named the 2024 recipient of the Society of NuclearMedicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He will be honored at the SNMMI's annual meeting in Toronto. Evans earned his PhD in organic chemistry from the Scripps Research Institute.
Cathy Sue Cutler, PhD, has been named president of the Society of NuclearMedicine and Molecular Imaging (SNMMI). She also intends to create training and education opportunities in theranostics and to educate the public on nuclearmedicine and its value. Cathy Sue Cutler, PhD. Cutler's awards are many.
tim.hodson Fri, 10/04/2024 - 10:51 Oct. 3, 2024 — GE HealthCare’s MIM Software has announced it received 510(k) clearance from the U.S. As Theranostics and the use of radiopharmaceutical therapy (RPT) to treat cancer and other diseases have become more prevalent, interest in using dosimetry to personalize RPT treatments has grown.
tim.hodson Fri, 11/01/2024 - 12:58 Blue Earth Therapeutics Ltd, recently announced further positive developments for its novel investigational radioligand therapies. Dosimetry of [ 177 Lu] Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comprehensive Systematic Review and Meta analysis."
For the hospital outpatient setting, Medicare currently packages the payment for radiopharmaceuticals into an overall payment for groupings of nuclearmedicine procedures including PET. This has led to inadequate payment for precision radiopharmaceuticals and challenges for some providers seeking to offer these imaging services.
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.
milla1cf Mon, 06/10/2024 - 18:25 June 10, 2024 — Jean-Luc C. Urbain, MD, PhD, FASNC, professor of Radiology/NuclearMedicine and Medicine, has been named president-elect of the Society of NuclearMedicine and Molecular Imaging (SNMMI).
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.
Jean-Luc Urbain, MD, PhD, has been named president-elect of the Society of NuclearMedicine and Molecular Imaging (SNMMI). Urbain, a professor of radiology and nuclearmedicine, has served in multiple roles within SNMMI, in addition to his most recent post as vice president-elect. Jean-Luc Urbain, MD, PhD. “As
CHICAGO Siemens Healthineers shined the spotlight on its new expanded photon-counting CT portfolio and the latest version of its Acuson Sequoia ultrasound scanner in its booth at RSNA 2024. Launched in December 2024, the Acuson Sequoia 3.5 The vendor also showcased Biograph One, a work-in-progress PET/MR scanner.
A nuclearmedicine hepatobiliary scan was also performed (not shown) and demonstrated no radiopharmaceutical present in the gallbladder due to cystic duct obstruction. The patient is pregnant (orange arrows), therefore ionizing radiation with CT scan or fluoroscopy can not be used for imaging guidance.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content